The Role of TNF-α in Rheumatoid Arthritis
DOI:
https://doi.org/10.54097/hset.v36i.6210Keywords:
Rheumatoid Arthritis, Tumor Necrosis Factor-Α, Articular Damage, TNF-Α Receptor, TNF-Α Inhibitor.Abstract
Rheumatoid arthritis (RA) induces articular damage through autoimmunity. Tumor necrosis factor-α (TNF-α) plays an important role in the pathogenesis of RA. TNF-α binds to its receptors to recruit certain molecules and forms two kinds of complexes (complex Ⅰ and Ⅱ) to regulate the pro-survival, apoptosis, and necrosis of cells. TNF-α upregulates RA by the methylation and acetylation of the RA synovial fibroblast gene and causes RA-derived joint damage through the induction of osteoclasts. Two TNF-α receptors mediate RA in opposite directions. TNF-α has been a target for the treatment of RA in which TNF-α inhibitors (TNFi) are administrated periodically for RA patients. Several mechanisms in the RA-related TNF-α signaling pathways remain imprecise including the regulation of regulatory T cells, osteoclast induction, and the potential interaction with the hypoxia-inducible factor. Further investigation into these questions may point out new methods for RA treatment to overcome the defects of current TNFi such as the anti-drug antibodies.
Downloads
References
Gravallese, E. M., Harada, Y., Wang, J. T., et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis [J]. The American journal of pathology, 1998, 152: 943 - 951.
Carswell, E. A., Old, L. J., Kassel, R. L., et al. An endotoxin-induced serum factor that causes necrosis of tumors [J]. Proceedings of the National Academy of Sciences of the United States of America, 1975, 72: 3666 - 3670.
Brenner, D., Blaser, H. & Mak, T. W. Regulation of tumour necrosis factor signalling: live or let die [J]. Nature reviews. Immunology, 2015, 15: 362 - 374.
Beg, A. A. & Baltimore, D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death [J]. Science (New York, N.Y.), 1996, 274: 782 - 784.
Gozzelino, R., Sole, C., Llecha, N., et al. BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs [J]. Cell Research, 2008, 18: 1020 - 1036.
Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes [J]. Cell, 2003, 114: 181 - 190.
Oberst, A., Dillon, C. P., Weinlich, R., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis [J]. Nature, 2011, 471: 363 - 367.
Wu, G., Chai, J., Suber, T. L., et al. Structural basis of IAP recognition by Smac/DIABLO [J]. Nature, 2000, 408: 1008 - 1012.
Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways [J]. Cell, 2008, 133: 693 - 703.
Tenev, T., Bianchi, K., Darding, M., et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs [J]. Molecular Cell, 2011, 43: 432 - 448.
Sun, L., Wang, H., Wang, Z., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase [J]. Cell, 2012, 148: 213 - 227.
Marchetti, L., Klein, M., Schlett, K., et al. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway [J]. The Journal of biological chemistry, 2004, 279: 32869 - 32881.
Rodriguez, M., Cabal-Hierro, L., Carcedo, M. T., et al. NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2 [J]. The Journal of biological chemistry, 2011, 286: 22814 - 22824.
Laurent, L., Clavel, C., Lemaire, O., et al. Fcgamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins [J]. Annals of the Rheumatic Diseases, 2011, 70: 1052 - 1059.
Kruglov, A., Drutskaya, M., Schlienz, D., et al. Contrasting contributions of TNF from distinct cellular sources in arthritis [J]. Annals of the Rheumatic Diseases, 2020, 79: 1453 - 1459.
Angiolilli, C., Grabiec, A. M., Ferguson, B. S., et al. Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression [J]. Annals of the Rheumatic Diseases, 2016, 75: 430 - 438.
Gowhari Shabgah, A., Shariati-Sarabi, Z., Tavakkol-Afshari, J., et al. Possible Anti-inflammatory Effects of Mesenchymal Stem Cells Transplantation via Changes in CXCL8 Levels in Patients with Refractory Rheumatoid Arthritis [J]. International journal of molecular and cellular medicine, 2019, 8: 191 - 199.
Boyce, B. F. & Xing, L. Biology of RANK, RANKL, and osteoprotegerin [J]. Arthritis Research & Therapy, 2007, 9 Suppl 1: S1.
Cohen, S. B., Dore, R. K., Lane, N. E., Ory, P. A., Peterfy, C. G., Sharp, J. T., van der Heijde, D., Zhou, L., Tsuji, W., Newmark, R. & Denosumab Rheumatoid Arthritis Study, G. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial [J]. Arthritis and rheumatism, 2008, 58: 1299 - 1309.
Yamashita, T., Yao, Z., Li, F., et al. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1 [J]. The Journal of biological chemistry, 2007, 282: 18245 - 18253.
Yao, Z., Xing, L., Qin, C., Schwarz, E. M. & Boyce, B. F. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism [J]. The Journal of biological chemistry, 2008, 283: 9917 - 9924.
Mori, L., Iselin, S., De Libero, G. & Lesslauer, W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice [J]. Journal of immunology (Baltimore, Md.: 1950), 1996, 157: 3178 - 3182.
Tseng, W. Y., Huang, Y. S., Clanchy, F., et al. TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells [J]. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116: 21666 - 21672.
Fischer, R., Proske, M., Duffey, M., et al. Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis [J]. Arthritis & rheumatology (Hoboken, N.J.), 2018, 70: 722 - 735.
Lamontain, V., Schmid, T., Weber-Steffens, D., et al. Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice [J]. Cellular & molecular immunology, 2019, 16: 65 - 74.
Nie, H., Zheng, Y., Li, R., et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis [J]. Nature Medicine, 2013, 19: 322 - 328.
Santinon, F., Batignes, M., Mebrek, M. L., et al. Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis [J]. Arthritis & rheumatology (Hoboken, N.J.), 2020, 72: 576 - 587.
Tang, W., Lu, Y., Tian, Q. Y., et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice [J]. Science (New York, N.Y.), 2011, 332: 478 - 484.
Fu, W., Hu, W., Yi, Y. S., et al. TNFR2/14-3-3epsilon signaling complex instructs macrophage plasticity in inflammation and autoimmunity [J]. The Journal of clinical investigation, 2021, 131: e144016.
Kobayashi, K., Takahashi, N., Jimi, E., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction [J]. The Journal of experimental medicine, 2000, 191: 275 - 286.
Kim, N., Kadono, Y., Takami, M., et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis [J]. The Journal of experimental medicine, 2005, 202: 589 - 595.
Li, J., Sarosi, I., Yan, X. Q., et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism [J]. Proceedings of the National Academy of Sciences of the United States of America, 2000, 97: 1566 - 1571.
Lam, J., Takeshita, S., Barker, J. E., et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand [J]. The Journal of clinical investigation, 2000, 106: 1481 - 1488.
Maid, P. J., Xavier, R., Real, R. M., et al. Incidence of Antidrug Antibodies in Rheumatoid Arthritis Patients From Argentina Treated With Adalimumab, Etanercept, or Infliximab in a Real-World Setting [J]. Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases, 2018, 24: 177 - 182.
Vultaggio, A., Matucci, A., Nencini, F., et al. Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions [J]. Allergy, 2010, 65: 657 - 661.
Korswagen, L. A., Bartelds, G. M., Krieckaert, C. L., et al. Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort study [J]. Arthritis and rheumatism, 2011, 63: 877-883.
Hot, A., Zrioual, S., Lenief, V. & Miossec, P. IL-17 and tumour necrosis factor alpha combination induces a HIF-1alpha-dependent invasive phenotype in synoviocytes [J]. Annals of the Rheumatic Diseases, 2012, 71: 1393 - 1401.
Nakajima, K., Itoh, K., Nagatani, K., et al. Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis [J]. Scandinavian journal of rheumatology, 2007, 36: 365 - 372.
Lee, J. W., Lee, J., Um, S. H. et al. Synovial cell death is regulated by TNF-alpha-induced expression of B-cell activating factor through an ERK-dependent increase in hypoxia-inducible factor-1alpha [J]. Cell death & disease, 2017, 8: e2727.
Lee, G. H., Lee, J., Lee, J. W., et al. B cell activating factor-dependent expression of vascular endothelial growth factor in MH7A human synoviocytes stimulated with tumor necrosis factor-alpha [J]. International Immunopharmacology, 2013, 17: 142 - 147.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
